A carregar...

Poxviral-based vaccine elicits immunologic responses in prostate cancer patients

Prostvac is a poxviral-based vaccine designed to target prostate-specific antigen (PSA) in prostate cancer patients. Recently, the potential toxicity and immunological impact of this immunotherapy were reviewed in the context of new clinical data. Our findings suggest that Prostvac is safe and elici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Madan, Ravi A, Heery, Christopher R, Gulley, James L
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091323/
https://ncbi.nlm.nih.gov/pubmed/25097802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28611
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!